Skip to main content



diversity in drug development

How teams can use technology to address issues of diversity across the drug and device development lifecycle.

insights management for clinical teams

Prior to 2020, many clinical teams approached virtual engagement with an experimental mindset. But when COVID-19 derailed trials and changed how global teams worked together, clinical groups quickly learned the benefits of combining asynchronous virtual engagement with live touchpoints. In this white paper, clinical team leads will learn how their peers are using hybrid virtual engagement to get more actionable insights, prioritize patient-centricity, gather more diverse perspectives, and overcome budget limitations.

better congress planning

The new, tech-enabled approach to congress planning adds value to medical conference attendance – before, during, and after the event.

better medical congress planning

How life science teams can achieve their targets through improved digital opinion leader selection.